NUBEQA (darolutamide) 300 mg tablets logo NUBEQA (darolutamide) 300 mg tablets logo
STAY CONNECTED
NUBEQA (darolutamide) 300 mg tablets logo NUBEQA (darolutamide) 300 mg tablets logo
STAY CONNECTED

Español

LIFE CHANGES WHAT YOU LOVE DOESN'T HAVE TO

Banner stating NUBEQA is the number one prescribed therapy among androgen receptor pathway inhibitors for new metastatic prostate cancer patients responding to ADT.

*Source: Based on Q1 2026, IQVIA Syndicated Prostate Cancer Tracker for US market conducted between January – March 2026.
THIS INFORMATION DOES NOT IMPLY SAFETY OR EFFICACY OF ANY PRODUCT: NO COMPARISONS SHOULD BE MADE. New patients are defined as patients who have been on their current treatment for 3 months or less based on patient chart audit and have not been switched from any other androgen receptor blockers in this period.

†ADT refers to a medical or surgical treatment that lowers testosterone.

NUBEQA (new-BECCA) is a pill used to treat certain types of metastatic and non-metastatic advanced prostate cancer

Tablet Icon

What is NUBEQA?

Learn how NUBEQA works, how to access financial support programs, and more.

Open the Patient Brochure PDF Icon

Question mark icon

Considering NUBEQA?

Learn how to talk to your doctor about whether NUBEQA may be right for you.

Open the Doctor
Discussion Guide PDF Icon

An icon depicting a protection shield with a check mark symbolizing safety

Ready to start?

Learn how Bayer Access Services can help you navigate coverage. Explore the 1-month FREE trial and $0 co-pay program.

See Savings & Support arrow icon

Audio icon

Press to hear pronunciation of NUBEQA (new-BECCA)

Discover NUBEQA® results

Talk to your doctor about the type of cancer you have and how NUBEQA might fit into your treatment plan.

METASTATIC

Your prostate cancer has spread to other parts of the body (metastatic) and responds to ADT.*

Graphic of prostate cancer spreading to other parts of the body, labeled as metastatic

METASTATIC Results icon arrow right white orange

NON-METASTATIC

Your prostate cancer has not spread to other parts of the body (non-metastatic) and does not respond to ADT.*

Graphic of prostate cancer not spreading to other parts of the body, labeled as non-metastatic

NON-METASTATIC Results icon arrow right white light blue.

ADT=androgen deprivation therapy.

*ADT refers to a medical or surgical treatment that lowers testosterone.

Are you a caregiver exploring NUBEQA? 
Support your loved one at every step.

See Caregiver's Guide to NUBEQA Icon arrow right orange white

Alt tag

Tony Romo and Bayer have teamed up to celebrate the patients taking NUBEQA and honor the things they love.

Joining them is Tony's dad, Ramiro Romo, who faced prostate cancer himself.

Together, they shine a light on these meaningful moments, both big and small, shared by patients taking NUBEQA and their loved ones.

Watch the full video icon-arrow-right

Tony does not have prostate cancer and Ramiro does not take NUBEQA.

Watch the full video icon-arrow-right

Real Patients, Real Stories

Hear stories from men taking NUBEQA and their care partners

Steve shares how finding the right doctor was important to his treatment with NUBEQA

Dr. Green (retired urologist and NUBEQA patient) is thankful for his
wife's support

Ryan and Tiffany share tips for managing your mindset
after diagnosis

Important Safety Information

Important Safety Information

Before taking NUBEQA, tell your healthcare provider about all your medical conditions, including if you:

  • have heart problems, high blood pressure, diabetes, or high amounts of fat or cholesterol in your blood (dyslipidemia)
  • have a history of seizures, brain injury, stroke, or brain tumors
  • have kidney or liver problems
  • are pregnant or plan to become pregnant. NUBEQA can cause harm to your unborn baby and loss of pregnancy (miscarriage)
  • have a partner who may become pregnant. Males who have female partners who may become pregnant should use effective birth control (contraception) during treatment and for 1 week after the last dose of NUBEQA. Talk with your healthcare provider about birth control methods
  • are breastfeeding or plan to breastfeed. It is not known if NUBEQA passes into breast milk

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. NUBEQA may affect the way other medicines work and other medicines may affect how NUBEQA works.

You should not start or stop any medicine before you talk with the healthcare provider that prescribed NUBEQA.

Know the medicines you take. Keep a list of them with you to show to your healthcare provider and pharmacist when you get a new medicine.

NUBEQA may cause serious side effects, including:

  • Heart disease. Blockage of the arteries in the heart (ischemic heart disease) that can lead to death has happened in some people during treatment with NUBEQA. Your healthcare provider will monitor you for signs and symptoms of heart problems during your treatment with NUBEQA. Call your healthcare provider or get medical help right away if you get chest pain or discomfort at rest or with activity, or shortness of breath during your treatment with NUBEQA.
  • Seizure. Treatment with NUBEQA may increase your risk of having a seizure. You should avoid activities where a sudden loss of consciousness could cause serious harm to yourself or others. Tell your healthcare provider right away if you have loss of consciousness or seizure during treatment with NUBEQA.

The most common side effects of NUBEQA include:

  • increase in liver function tests
  • decreased white blood cells (neutropenia)
  • feeling more tired than usual

The most common side effects of NUBEQA in combination with docetaxel include:

  • constipation
  • rash
  • decreased appetite
  • bleeding
  • weight gain
  • high blood pressure
  • decreased red blood cells (anemia)
  • high blood sugar levels
  • decreased white blood cells
  • increase in liver function tests
  • low blood calcium levels

NUBEQA may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility.

These are not all the possible side effects of NUBEQA.

Call your healthcare provider for medical advice about side effects. You are encouraged to report side effects or quality complaints of products to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.

Please see the full Prescribing Information.

<span>WHAT IS NUBEQA<sup>®</sup>?</span>

WHAT IS NUBEQA®?

NUBEQA® (darolutamide) is a prescription medicine used to treat adults with prostate cancer:

  • that has not spread to other parts of the body and no longer responds to a medical or surgical treatment that lowers testosterone
  • that has spread to other parts of the body and responds to a medical or surgical treatment that lowers testosterone
  • that has spread to other parts of the body and responds to a medical or surgical treatment that lowers testosterone in combination with docetaxel.

It is not known if NUBEQA is safe and effective in females or children.

© 2026 Bayer. All rights reserved. BAYER, the Bayer Cross and NUBEQA are registered trademarks of Bayer, and Access Services by Bayer is a trademark of Bayer.

Date of last update: 9/17/2026